is the first Asian tissue bank approved
by US FDA and we produce safe and high
quality allograft products and biological
implants in accordance with guidelines and/or
standards of US FDA,
EATB (European Association of Tissue Bank),
and AATB (American Association of Tissue
Bank). About 60
researchers and quality control personnel
are working at HansBiomed Research & Development
to ensure the safety and quality of and
to improve these products. HDI has an intellectual
including human dermal matrix processing.
Our mission is to be
the ideal partner for aesthetic and reconstructive
solutions to help healthcare
professionals make a real and long-lasting
difference to the well-being of patients,
empowering them to lead
healthier and more satisfying lives.
Science and innovation
HansBiomed Corp. is dedicated
to providing innovative, safe and effective
health solutions with supportive
scientific evidences. We have been pursuing
for development of innovating new products
surgery and human tissue engineering field
since the establishment of the company.
Thanks to allocation of
more than 20% corporate revenue to the research
and development, we now become competitive
brand products worldwide.